Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles E Alpers

Showing results (1-10 of 267) with videos related to

Pageof 27
Sort By:
The Journal of Rheumatology|February 1, 2024
Antiphospholipid Antibodies (aPL) and Thrombotic Microangiopathy for the Diagnosis of aPL Nephropathy: You Can't Have One Without the OtherCharles E Alpers
Kidney International|April 20, 2024
Seeing through the density of dense deposit diseaseCharles E Alpers
Kidney International|December 11, 2002
Light at the end of the TUNEL: HIV-associated thrombotic microangiopathyCharles E Alpers
Current Opinion in Nephrology and Hypertension|April 17, 2003
Chemokines and chemokine receptors in renal pathologyStephan Segerer, Charles E Alpers
Journal of the American Society of Nephrology : JASN|November 30, 2007
Fibrillary glomerulonephritis and immunotactoid glomerulopathyCharles E Alpers, Jolanta Kowalewska
Clinical Journal of the American Society of Nephrology : CJASN|September 19, 2007
Emerging paradigms in the renal pathology of viral diseasesCharles E Alpers, Jolanta Kowalewska
Kidney International Supplements|August 28, 2015
What is the best way to measure renal fibrosis?: A pathologist's perspectiveAlton B Farris, Charles E Alpers
Current Opinion in Nephrology and Hypertension|April 15, 2008
Cryoglobulinemia and renal diseaseCharles E Alpers, Kelly D Smith
Kidney International|September 23, 2022
Lupus nephritis transcriptomics across space and timeShaun W Jackson, Charles E Alpers
Nature Reviews. Nephrology|February 6, 2013
Glomerular disease: 'suPAR'-exciting times for FSGSJ Ashley Jefferson, Charles E Alpers
Pageof 27

Showing results (1-10 of 267) with videos related to

Sort By:
Pageof 27
The Journal of Rheumatology|February 1, 2024
Antiphospholipid Antibodies (aPL) and Thrombotic Microangiopathy for the Diagnosis of aPL Nephropathy: You Can't Have One Without the OtherCharles E Alpers
Kidney International|April 20, 2024
Seeing through the density of dense deposit diseaseCharles E Alpers
Kidney International|December 11, 2002
Light at the end of the TUNEL: HIV-associated thrombotic microangiopathyCharles E Alpers
Current Opinion in Nephrology and Hypertension|April 17, 2003
Chemokines and chemokine receptors in renal pathologyStephan Segerer, Charles E Alpers
Journal of the American Society of Nephrology : JASN|November 30, 2007
Fibrillary glomerulonephritis and immunotactoid glomerulopathyCharles E Alpers, Jolanta Kowalewska
Clinical Journal of the American Society of Nephrology : CJASN|September 19, 2007
Emerging paradigms in the renal pathology of viral diseasesCharles E Alpers, Jolanta Kowalewska
Kidney International Supplements|August 28, 2015
What is the best way to measure renal fibrosis?: A pathologist's perspectiveAlton B Farris, Charles E Alpers
Current Opinion in Nephrology and Hypertension|April 15, 2008
Cryoglobulinemia and renal diseaseCharles E Alpers, Kelly D Smith
Kidney International|September 23, 2022
Lupus nephritis transcriptomics across space and timeShaun W Jackson, Charles E Alpers
Nature Reviews. Nephrology|February 6, 2013
Glomerular disease: 'suPAR'-exciting times for FSGSJ Ashley Jefferson, Charles E Alpers
Pageof 27